Gossamer Bio Inc. (GOSS)
NASDAQ: GOSS
· Real-Time Price · USD
1.30
-0.06 (-4.41%)
At close: Jun 26, 2025, 3:59 PM
1.35
3.39%
Pre-market: Jun 27, 2025, 08:43 AM EDT
-4.41% (1D)
| Bid | 1.3 |
| Market Cap | 296.63M |
| Revenue (ttm) | 124.59M |
| Net Income (ttm) | -51.24M |
| EPS (ttm) | -0.22 |
| PE Ratio (ttm) | -5.93 |
| Forward PE | -2.87 |
| Analyst | Buy |
| Ask | 1.35 |
| Volume | 1,126,678 |
| Avg. Volume (20D) | 1,541,996 |
| Open | 1.36 |
| Previous Close | 1.36 |
| Day's Range | 1.29 - 1.37 |
| 52-Week Range | 0.66 - 1.55 |
| Beta | 1.85 |
About GOSS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GOSS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GOSS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Gossamer Bio Inc. is scheduled to release its earnings on Aug 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+3.23%
Gossamer Bio shares are trading higher after the c...
Unlock content with
Pro Subscription
2 weeks ago · https://www.defenseworld.net
Squarepoint Ops LLC Has $65,000 Stake in Gossamer Bio, Inc. (NASDAQ:GOSS)Squarepoint Ops LLC trimmed its stake in Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) by 51.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutiona...
1 month ago · seekingalpha.com
Gossamer Bio, Inc. (GOSS) Q1 2025 Earnings Conference Call TranscriptGossamer Bio, Inc. (NASDAQ:GOSS ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Bryan Giraudo - COO & CFO Faheem Hasnain - Co-Founder, CEO, President & Chairman Richard...
